Cook Islands plants show regenerative properties

A skin care product based on plants used in traditional Cook Islands remedies has been created by UNSW researchers who are also investigating the regenerative properties of the plants for use in wound and bone healing.

The TeTika cosmetics, developed with the company Cimtech's BioActive Cook Islands oil, incorporates traditional Cook Islands medicines.

TeTika means 'truth and integrity' in Cook Islands Maori.

In 2003, Dr Graham Matheson and UNSW Medicine's Professor Bill Walsh began investigating the regenerative properties of plants in partnership with the local traditional leaders.

Dr Matheson, who has completed a PhD at UNSW based on the project, founded a company that permits traditional owners to share in financial benefits from his research, which has received support from UNSW's commercialisation company, NewSouth Innovations. The company was most recently supported by Australia.

"The University and the traditional leaders and I entered into an agreement that is currently being discussed around the world at biodiversity forums as towards world's best practice in access and benefit sharing," Dr Matheson says.

Dr Matheson and Professor Walsh are now investigating that promote new and skin healing. Professor Walsh says research using the plants is a continued collaborative project.

Dr Matheson and UNSW are major shareholders in the company, Cimtech.

More information: tetika.com.au/

add to favorites email to friend print save as pdf

Related Stories

Water wonder

May 13, 2011

A brilliant water saving idea by UNSW engineering academics Greg Leslie and Bruce Sutton has impressed the judges on ABC TV’s New Inventors program.

Saltwater solution to save crops

Sep 11, 2008

Technology under development at the University of New South Wales could offer new hope to farmers in drought-affected and marginal areas by enabling crops to grow using salty groundwater.

Recommended for you

WHO: Millions of Ebola vaccine doses ready in 2015

Oct 24, 2014

The World Health Organization says millions of doses of two experimental Ebola vaccines could be ready for use in 2015 and five more experimental vaccines will start being tested in March.

Added benefit of vedolizumab is not proven

Oct 23, 2014

Vedolizumab (trade name Entyvio) has been approved since May 2014 for patients with moderately to severely active Crohn disease or ulcerative colitis. In an early benefit assessment pursuant to the Act on the Reform of the ...

Seaweed menace may yield new medicines

Oct 22, 2014

An invasive seaweed clogging up British coasts could be a blessing in disguise. University of Greenwich scientists have won a cash award to turn it into valuable compounds which can lead to new, life-saving drugs.

User comments